1 Threads
#ESC20 PARALLAX Trial 🧵 -2,566 HF patients (LVEF >40%) -Sacubitril-Valsartan vs Active-controlled treatment (Enalapril, Valsartan or Placebo) -Primary endpoint: NTproBNP at 12 wee...
Loading more...
Paste a thread URL like https://x.com/user/status/123456789 or just the tweet ID
https://x.com/user/status/123456789
